Boston Scientific is working to restore systems after a cyberattack disrupted operations around the world, including its ability to process and ship customer orders.
After detecting the incident on August 25, the medical device manufacturer activated its incident response procedures and brought in outside cybersecurity experts to investigate and contain the threat. Details about what caused the attack remain limited, and there is no timeline for when operations will return to normal.
The investigation is ongoing as Boston Scientific works to determine the full scope and consequences of the incident.
Why It Matters: Boston Scientific’s cyberattack puts operational resilience in focus, with disruptions to internal systems and order fulfillment across its global operations. How those systems depend on one another can play a major role in recovery and how quickly the business returns to normal.
- Operational Disruption: The network outage restricted access to operating systems and business applications across Boston Scientific’s global operations, affecting systems employees rely on for day-to-day work. In Cork, Ireland, the disruption reportedly led to thousands of employees being sent home after network communications were cut, showing how the incident has already affected operations outside of processing and shipping.
- Order Fulfillment: Systems used to process and ship customer orders are among those affected, disrupting part of Boston Scientific’s normal order fulfillment process. The interruption is playing out across a company that employs about 59,000 people, operates 13 manufacturing facilities and has a presence in 127 countries. Boston Scientific generated more than $20 billion in revenue in 2025.
- Recovery Timeline: Work is underway to restore affected functions and system access, though the company has not provided a timeline for full recovery and expects some disruptions to continue. In its SEC filing, Boston Scientific said it is still assessing the nature and scope of the incident, along with its potential operational and financial consequences. Shares fell as much as 6% in early trading following the disclosure.
- Inside the Investigation: Details about the intrusion remain limited, with the type of attack, identity of the attacker and initial access method still unknown. The company has also not determined publicly whether any information was accessed or stolen. No known ransomware or data-extortion group had claimed responsibility at the time of reporting, leaving the nature of the incident and who may be behind it unresolved.
- Patient Considerations: Boston Scientific says its technologies treat roughly 48 million patients each year, with products ranging from pacemakers and defibrillators to stents, catheters and endoscopes. The company has not said whether patients or implanted devices have been affected or whether any precautions are necessary. The incident follows cyberattacks involving other major medical technology companies, including Abbott Laboratories, Medtronic and Stryker, earlier in 2026.
Go Deeper -> Boston Scientific says a cyberattack is disrupting its global operations – CBS News
Boston Scientific says cyberattack disrupted operations globally – BleepingComputer
